RELATED CONTENT
NEWS
- AstraZeneca dumps Targacept's antidepressant TC-5214 after two more Ph III failures
- AstraZeneca to take $381.5 million charge after two major trial failures
- Lundbeck CEO outlines commercial strategy for alcohol-dependency and depression candidates
- Alkermes' PhII ALKS-5461: new mechanism, opiate receptor modulation, for refractory depression
COMMENT
Other Informa Comment
FEATURES
Other Informa Features
EVENTS
Today
The Rembrandt Hotel, London
07 June 2012
The Rembrandt Hotel, London
12 June 2012
Annecy, France
JOB OF THE WEEK

Section Head (m/f)
DRA International/CIS Section

Section Head (m/f)
DRA International/CIS Section

